Relationship between advanced glycation end products and gestational diabetes mellitus

References

• Catalano PM. Trying to understand gestational diabetes. Diabet Med. 2014;31(3):273–281.
   PubMed Web of Science ®Google Scholar
• The Chinese Medical Association Chinese Society of Obstetrics and Gynecology Society Obstetrics Group and the Chinese Medical Association Chinese Society of Perinatal Medicine Diabetic Pregnancy Study Group. Diagnosis and treatment of diabetes in pregnancy guideline (2014). Chin J Obstet Gynecol. 2014;49(8):561–569.
   Google Scholar
• Baz B, Riveline JP, Gautier JF. Endocrinology of pregnancy: gestational diabetes mellitus: definition, aetiological and clinical aspects. Eur J Endocrinol. 2016;174(2):R43–R51.
   PubMed Web of Science ®Google Scholar
• Abell SK, De Courten B, Boyle JA, et al. Inflammatory and other biomarkers: role in pathophysiology and prediction of gestational diabetes mellitus. Int J Mol Sci. 2015;16(6):13442–13473.
   PubMed Web of Science ®Google Scholar
• Vrachnis N, Belitsos P, Sifakis S, et al. Role of adipokines and other inflammatory mediators in gestational diabetes mellitus and previous gestational diabetes mellitus. Int J Endocrinol. 2012;2012:549748.
   PubMed Web of Science ®Google Scholar
• Uribarri J, Woodruff S, Goodman S, et al. Advanced glycation end products in foods and a practical guide to their reduction in the diet. J Am Diet Assoc. 2010;110(6):911–916.e12.
   PubMedGoogle Scholar
• Rabbani N, Thornalley PJ. Glycation research in amino acids: a place to call home. Amino Acids. 2012;42(4):1087–1096.
   PubMed Web of Science ®Google Scholar
• Tessier FJ. The Maillard reaction in the human body. The main discoveries and factors that affect glycation. Pathol Biol (Paris). 2010;58(3):214–219.
   PubMedGoogle Scholar
• Poulsen MW, Hedegaard RV, Andersen JM, et al. Advanced glycation endproducts in food and their effects on health. Food Chem Toxicol. 2013;60:10–37.
   PubMed Web of Science ®Google Scholar
• Luevano-Contreras C, Chapman-Novakofski K. Dietary advanced glycation end products and aging. Nutrients. 2010;2(12):1247–1265.
   PubMed Web of Science ®Google Scholar
• Vlassara H, Uribarri J. Advanced glycation end products (AGE) and diabetes: cause, effect, or both? Curr Diab Rep. 2014;14(1):453.
   PubMed Web of Science ®Google Scholar
• Edeas M, Attaf D, Mailfert AS, et al. Maillard Reaction, mitochondria and oxidative stress: potential role of antioxidants. Pathol Biol (Paris). 2010;58(3):220–225.
   PubMedGoogle Scholar
• Hachiya H, Miura Y, Inoue K, et al. Advanced glycation end products impair glucose-induced insulin secretion from rat pancreatic beta-cells. J Hepato Biliary Pancreat Sci. 2014;21(2):134–141.
   PubMed Web of Science ®Google Scholar
• Shu T, Zhu Y, Wang H, et al. AGEs decrease insulin synthesis in pancreatic beta-cell by repressing Pdx-1 protein expression at the post-translational level. PLoS One. 2011;6(4):e18782.
   PubMed Web of Science ®Google Scholar
• Tang X, Qin Q, Xie X, et al. Protective effect of sRAGE on fetal development in pregnant rats with gestational diabetes mellitus. Cell Biochem Biophys. 2015;71(2):549–556.
   PubMed Web of Science ®Google Scholar
• Bartakova V, Kollarova R, Kuricova K, et al. Serum carboxymethyl-lysine, a dominant advanced glycation end product, is increased in women with gestational diabetes mellitus. Biomed Pap Med Fac Univ Palacky Olomouc Czech Repub. 2016;160(1):70–75.
   PubMed Web of Science ®Google Scholar
• Boutzios G, Livadas S, Piperi C, et al. Polycystic ovary syndrome offspring display increased oxidative stress markers comparable to gestational diabetes offspring. Fertil Steril. 2013;99(3):943–950.
   PubMed Web of Science ®Google Scholar
• Lobo JP, Brescansin CP, Santos-Weiss ICR, et al. Serum Fluorescent Advanced Glycation End (F-AGE) products in gestational diabetes patients. Arch Endocrinol Metab. 2017;61(3):233–237.
   PubMed Web of Science ®Google Scholar
• de Ranitz-Greven WL, Kaasenbrood L, Poucki WK, et al. Advanced glycation end products, measured as skin autofluorescence, during normal pregnancy and pregnancy complicated by diabetes mellitus. Diabetes Technol Ther. 2012;14(12):1134–1139.
   PubMed Web of Science ®Google Scholar
• Alexander KL, Mejia CA, Jordan C, et al. Differential receptor for advanced glycation end products expression in preeclamptic, intrauterine growth restricted, and gestational diabetic placentas. Am J Reprod Immunol. 2016;75(2):172–180.
   PubMed Web of Science ®Google Scholar
• Ott C, Jacobs K, Haucke E, et al. Role of advanced glycation end products in cellular signaling. Redox Biol. 2014;2:411–429.
   PubMed Web of Science ®Google Scholar
• Fröhlich M, Imhof A, Berg G, et al. Association between C-reactive protein and features of the metabolic syndrome: a population-based study. Diabetes Care. 2000;23(12):1835–1839.
   PubMed Web of Science ®Google Scholar
• Ozgu-Erdinc AS, Yilmaz S, Yeral MI, et al. Prediction of gestational diabetes mellitus in the first trimester: comparison of C-reactive protein, fasting plasma glucose, insulin and insulin sensitivity indices. J Matern Fetal Neonatal Med. 2015;28(16):1957–1962.
   PubMed Web of Science ®Google Scholar
• Xu J, Zhao YH, Chen YP, et al. Maternal circulating concentrations of tumor necrosis factor-alpha, leptin, and adiponectin in gestational diabetes mellitus: a systematic review and meta-analysis. Sci World J. 2014;2014:926932.
   Web of Science ®Google Scholar
• Noureldeen AF, Qusti SY, Al-Seeni MN, et al. Maternal leptin, adiponectin, resistin, visfatin and tumor necrosis factor-alpha in normal and gestational diabetes. Indian J Clin Biochem. 2014;29(4):462–470.
   PubMedGoogle Scholar
• Uribarri J, Cai W, Woodward M, et al. Elevated serum advanced glycation endproducts in obese indicate risk for the metabolic syndrome: a link between healthy and unhealthy obesity? J Clin Endocrinol Metab. 2015;100(5):1957–1966.
   PubMed Web of Science ®Google Scholar
• Su XD, Li SS, Tian YQ, et al. Elevated serum levels of advanced glycation end products and their monocyte receptors in patients with Type 2 diabetes. Arch Med Res. 2011;42(7):596–601.
   PubMed Web of Science ®Google Scholar
• Tan KCB, Shiu SW, Wong Y, et al. Serum advanced glycation end products (AGEs) are associated with insulin resistance. Diabetes Metab Res Rev. 2011;27(5):488–492.
   PubMed Web of Science ®Google Scholar
• Tahara N, Yamagishi S, Matsui T, et al. Serum levels of advanced glycation end products (AGEs) are independent correlates of insulin resistance in nondiabetic subjects. Cardiovasc Ther. 2012;30(1):42–48.
   PubMed Web of Science ®Google Scholar
• Pertyńska-Marczewska M, Głowacka E, Sobczak M, et al. Glycation endproducts, soluble receptor for advanced glycation endproducts and cytokines in diabetic and non-diabetic pregnancies. Am J Reprod Immunol. 2009;61(2):175–182.
   PubMed Web of Science ®Google Scholar
• Yu Y, Hanssen KF, Kalyanaraman V, et al. Reduced soluble receptor for advanced glycation end-products (sRAGE) scavenger capacity precedes pre-eclampsia in Type 1 diabetes. BJOG. 2012;119(12):1512–1520.
   PubMed Web of Science ®Google Scholar
• Kalea AZ, Schmidt AM, Hudson BI. Alternative splicing of RAGE: roles in biology and disease[J]. Front Biosci (Landmark Ed). 2011;1(16):2756–2770.
   Web of Science ®Google Scholar